These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34214131)

  • 1. Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
    Dickey BL; Sirak B; Martin-Gomez L; Reich RR; Abrahamsen M; Isaacs-Soriano K; Chung CH; Giuliano AR
    PLoS One; 2021; 16(7):e0254161. PubMed ID: 34214131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwash.
    Pierce Campbell CM; Guan W; Sprung R; Koomen JM; O'Keefe MT; Ingles DJ; Abrahamsen M; Giuliano AR
    J Immunol Methods; 2013 Dec; 400-401():117-21. PubMed ID: 24140751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
    Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
    Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
    Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
    Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
    Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
    Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
    Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.
    Rahman S; Pierce Campbell CM; Torres BN; O'Keefe MT; Ingles DJ; Villa LL; Carvalho da Silva RJ; Cintra RC; Lazcano-Ponce E; Salmeron J; Quiterio M; Giuliano AR
    Oral Dis; 2016 Nov; 22(8):781-790. PubMed ID: 27470907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma.
    Quabius ES; Görögh T; Fischer GS; Hoffmann AS; Gebhard M; Evert M; Beule A; Maune S; Knecht R; Óvári A; Durisin M; Hoppe F; Röcken C; Hedderich J; Ambrosch P; Hoffmann M
    Cancer Lett; 2015 Feb; 357(1):339-345. PubMed ID: 25462861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
    Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
    Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
    Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H
    J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of human papillomavirus and oropharyngeal cancer.
    D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
    N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
    Shugars DC; Watkins CA; Cowen HJ
    Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics.
    Giuliano AR; Nedjai B; Lorincz AT; Schell MJ; Rahman S; Banwait R; Boulware D; Sirak B; Martin-Gomez L; Abrahamsen M; Isaacs-Soriano KA; Wenig B; Chung CH; Caudell J
    Int J Cancer; 2020 Feb; 146(4):1018-1030. PubMed ID: 31304592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
    Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
    Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer.
    Dickey BL; Nedjai B; Preece MD; Schell MJ; Boulware D; Whiting J; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Kennedy K; Chung CH; Giuliano AR
    Cancer Med; 2022 Oct; 11(20):3735-3742. PubMed ID: 35619332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study.
    Laprise C; Madathil SA; Schlecht NF; Castonguay G; Soulières D; Nguyen-Tan PF; Allison P; Coutlée F; Hier M; Rousseau MC; Franco EL; Nicolau B
    Head Neck; 2019 Mar; 41(3):678-685. PubMed ID: 30605251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases.
    Martin-Gomez L; Fulp WJ; Schell MJ; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Lorincz A; Wenig B; Chung CH; Caudell JJ; Giuliano AR
    Oral Oncol; 2019 May; 92():85-91. PubMed ID: 31010629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.